IFF, after brief leadership stint under Merck's Frank Clyburn, pawns off pharma solutions business for $2.85B
Fierce Pharma
MARCH 19, 2024
New York's IFF—which dabbles in food, beverage, beauty and pharmaceutical supply chains, among others—has agreed to sell its pharma solutions business to French plant-based ingredient maker Roquette for up to $2.85 After a two-year stint under Merck & Co.
Let's personalize your content